Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115286628B details palladium catalyzed carbonylation for high purity intermediates offering cost reduction and supply chain reliability for pharmaceutical manufacturing.
A novel metal-free photocatalytic method for preparing deuterated intermediates using visible light, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN117720537B reveals novel catalyst enabling high-purity asymmetric synthesis with reduced costs and scalable supply chain reliability for global buyers.
Patent CN114524701B reveals a novel organocatalytic route for N-N axis chiral pyrroles with high cytotoxicity, offering cost-effective API intermediate manufacturing solutions.
Patent CN114524701B reveals a novel chiral phosphoric acid catalyzed route for N-N axis chiral pyrroles with high enantioselectivity and cytotoxic activity.
Novel catalyst-free N-methylation using formic acid and triethylamine in DMSO. High yields, broad substrate scope, suitable for industrial scale-up of fine chemicals.
Patent CN101891668B reveals novel L-prolineamide catalysts enabling high-yield, metal-free asymmetric synthesis. Ideal for reliable pharmaceutical intermediate supplier strategies.
Patent CN112574107B reveals a streamlined Pd-catalyzed C-H activation route for high-purity atropisomeric intermediates, offering significant supply chain advantages.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole styrenes, offering high enantioselectivity and mild conditions for scalable pharmaceutical intermediate production.
Patent CN116786165B reveals efficient tungsten catalyst for aniline coupling. Offers cost reduction and green manufacturing for pharmaceutical intermediates supply chains.
Novel cobalt method replaces rhodium and palladium for carbazole synthesis, offering significant cost reduction and high yields for pharmaceutical intermediates.
Novel oxindole-derived styrene phosphine catalysts enabling high-yield asymmetric cyclizations with mild conditions for fine chemical manufacturing.
Patent CN110002952B reveals efficient iridium catalysis for alpha,beta-unsaturated alcohols, offering cost-effective pharma intermediate synthesis.
Novel axial chiral phosphine catalyst synthesis via chiral phosphoric acid. High ee, mild conditions. Ideal for asymmetric hydrosilylation and coupling. Reliable supplier for pharma intermediates.
Efficient Ag2CO3 catalyzed synthesis of polysubstituted pyrroles from alkynes and isocyanides. Cost-effective pharma intermediate manufacturing with high purity.
Patent CN113195460A details enantioselective iridium-catalyzed hydrogenation of oximes. This breakthrough offers cost reduction in agrochemical intermediate manufacturing and reliable supply chain solutions.
Patent CN111848322B details a novel organocatalytic resolution for axially chiral styrenes. Discover cost-effective, high-ee synthetic routes for pharmaceutical intermediates.
Patent CN101143862B details novel chiral ionic thiourea catalysts offering high enantioselectivity and recyclability for pharmaceutical intermediate manufacturing.
Patent CN106478719B details a novel camphor-based chiral catalyst. Offers high selectivity and metal-free advantages for pharmaceutical intermediates manufacturing cost reduction.
Novel biaryl-based ligand enables high-yield palladium-catalyzed asymmetric allylic substitution with exceptional enantioselectivity and simplified synthesis.